US FTC: 'Product-hopping' illegally impedes generic entry
The US Government is becoming increasingly critical of industry attempts to ward off competition through ‘product-hopping,’ an IP lawyer says.
The US Government is becoming increasingly critical of industry attempts to ward off competition through ‘product-hopping,’ an IP lawyer says.
A UK firm has launched a searchable database of genomic data from sources all over the world that it says will accelerate development of personalised medicines.
MannKind has cut more jobs in efforts to streamline operations, leaving the inhalable insulin manufacturer around a third smaller than this time last year.
Lonza has been contracted to develop a production process for a hepatitis C drug being trialled by gene silencing firm Benitec Biopharma.
Contractor Trenzyme GmbH has licensed a CHO cell line-based expression system from Swiss firm Celonic AG in a deal designed to expand its service offering.
Capsugel has seen growing pharma demand for vegetarian capsules with formulation benefits outweighing the fact they cost more than gelatin.